FOXO1 and heart failure: Although there is no direct clinical evidence of FoxO1 activation during DbCM, its DNA binding sites are overrepresented in the promoter sequences of heart failure genes in isolated RNA from the myocardium of heart failure patients with either ischemic or idiopathic dilated cardiomyopathy [42].